PD-L1抗體及其用途

• 收藏
• 分享

专利权人:

I-Mab Biopharma Co., Ltd.;天境生物科技（上海）有限公司

发明人:

FANG, Lei,WANG, Zhengyi,GUO, Bingshi,ZANG, Jingwu,GUO, Bingshi,郭炳詩,ZANG, Jingwu,臧敬五

申请号：

HK19101830

公开号：

HK1259426A1

申请日:

2019.01.31

申请国别(地区):

HK

年份:

2019

代理人:

摘要：

Provided are anti-PD-L1 antibodies or fragments thereof. The antibodies or fragments thereof specifically bind to the immunoglobulin C domain of the PD-L1 protein. In various example, the antibodies or fragments thereof include a VH CDR1 of SEQ ID NO: 1, a VH CDR2 of SEQ ID NO: 2, a VH CDR3 of SEQ ID NO: 3, a VL CDR1 of SEQ ID NO: 4, a VL CDR2 of SEQ ID NO: 5, and a VL CDR3 of SEQ ID NO: 6, or variants of each thereof. Methods of using the antibodies or fragments thereof for treating and diagnosing diseases such as cancer and infectious diseases are also provided.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/